Searching News Database: IgM
Your search returned too many results! The most recent 500 items are shown below:
HSMN NewsFeed - 23 Jun 2026
CereVasc, Inc. Completes Enrollment in STRIDE Pivotal Trial of the eShunt(R) System
CereVasc, Inc. Completes Enrollment in STRIDE Pivotal Trial of the eShunt(R) System
HSMN NewsFeed - 14 Apr 2026
Aegis Ventures and Wavelet Medical Aim to Redefine the Standard of Care in Fetal Medicine
Aegis Ventures and Wavelet Medical Aim to Redefine the Standard of Care in Fetal Medicine
HSMN NewsFeed - 12 Mar 2026
Ratio Therapeutics Appoints Global Medical Leader Colin Hayward as Chief Medical Officer
Ratio Therapeutics Appoints Global Medical Leader Colin Hayward as Chief Medical Officer
HSMN NewsFeed - 9 Mar 2026
Baird Medical Accelerates U.S. Expansion in Interventional Thyroidology at NASIT 2026
Baird Medical Accelerates U.S. Expansion in Interventional Thyroidology at NASIT 2026
HSMN NewsFeed - 3 Feb 2026
Industry Veteran and Med Tech Pioneer Appointed Special Advisor to ProVerum
Industry Veteran and Med Tech Pioneer Appointed Special Advisor to ProVerum
HSMN NewsFeed - 4 Nov 2025
Ratio Therapeutics Announces the Appointment of Marcel Reichen as Chief Strategy Officer
Ratio Therapeutics Announces the Appointment of Marcel Reichen as Chief Strategy Officer
HSMN NewsFeed - 8 Oct 2025
Lumen Bioscience Expands Board and Leadership Team to Advance Clinical Pipeline of Novel Oral Biologics
Lumen Bioscience Expands Board and Leadership Team to Advance Clinical Pipeline of Novel Oral Biologics
HSMN NewsFeed - 29 Jul 2025
Leo Cancer Care Receives FDA 510(k) Clearance for Marie(R) - A Revolutionary Upright Radiotherapy Platform
Leo Cancer Care Receives FDA 510(k) Clearance for Marie(R) - A Revolutionary Upright Radiotherapy Platform
HSMN NewsFeed - 30 Jun 2025
NewLines(TM) App Update Extends AI-Assisted SmartProfiles(TM) to the Android Platform
NewLines(TM) App Update Extends AI-Assisted SmartProfiles(TM) to the Android Platform
HSMN NewsFeed - 23 May 2025
England's NICE Recommends FILSPARI(R) (sparsentan) as a Treatment Option for IgA Nephropathy
England's NICE Recommends FILSPARI(R) (sparsentan) as a Treatment Option for IgA Nephropathy
HSMN NewsFeed - 1 Apr 2025
Zimmer Biomet Receives CE Mark Approval for RibFix Advantage(R) Fixation System
Zimmer Biomet Receives CE Mark Approval for RibFix Advantage(R) Fixation System
HSMN NewsFeed - 25 Mar 2025
Hubble Therapeutics Closes Series A Financing to Develop Gene Therapy Cure for LCA16
Hubble Therapeutics Closes Series A Financing to Develop Gene Therapy Cure for LCA16
HSMN NewsFeed - 19 Mar 2025
Terumo Neuro Celebrates 15 Years of the WEB(TM) Device: A Game-Changing Innovation in Aneurysm Treatment
Terumo Neuro Celebrates 15 Years of the WEB(TM) Device: A Game-Changing Innovation in Aneurysm Treatment
HSMN NewsFeed - 30 Jan 2025
Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation
Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation
HSMN NewsFeed - 11 Oct 2024
X-Bolt Announces First U.S. Implant of Pro-X1(R) Trochanteric Nailing System
X-Bolt Announces First U.S. Implant of Pro-X1(R) Trochanteric Nailing System
HSMN NewsFeed - 27 Sep 2024
Boston Scientific Receives Japanese Regulatory Approval for the FARAPULSE(TM) Pulsed Field Ablation System
Boston Scientific Receives Japanese Regulatory Approval for the FARAPULSE(TM) Pulsed Field Ablation System
HSMN NewsFeed - 12 Sep 2024
Inflammatix Secures $57 Million to Advance Novel Diagnostic for Patients with Suspected Infections or Sepsis
Inflammatix Secures $57 Million to Advance Novel Diagnostic for Patients with Suspected Infections or Sepsis
HSMN NewsFeed - 30 Jul 2024
ViaLase Receives CE Mark for First Femtosecond Laser for the Treatment of Glaucoma, the ViaLase(R) Laser
ViaLase Receives CE Mark for First Femtosecond Laser for the Treatment of Glaucoma, the ViaLase(R) Laser
HSMN NewsFeed - 9 Jul 2024
Beckman Coulter Introduces New Integrated Chemistry and Immunoassay Analyzer
Beckman Coulter Introduces New Integrated Chemistry and Immunoassay Analyzer
HSMN NewsFeed - 19 Jun 2024
European Commission grants Sobi(R) Marketing Authorisation for ALTUVOCT(TM) for treatment of haemophilia A
European Commission grants Sobi(R) Marketing Authorisation for ALTUVOCT(TM) for treatment of haemophilia A
HSMN NewsFeed - 14 May 2024
Nanoscope Therapeutics Appoints Khandan Baradaran as Senior Vice President of Regulatory and Quality
Nanoscope Therapeutics Appoints Khandan Baradaran as Senior Vice President of Regulatory and Quality
HSMN NewsFeed - 9 May 2024
OrthoXel Receives FDA 510(k) Clearance for their Vertex Hip Fracture Nail (HFN)
OrthoXel Receives FDA 510(k) Clearance for their Vertex Hip Fracture Nail (HFN)
HSMN NewsFeed - 23 Apr 2024
Flare Therapeutics Appoints Douglas Manion, M.D., FRCP (C) as Chief Executive Officer
Flare Therapeutics Appoints Douglas Manion, M.D., FRCP (C) as Chief Executive Officer
HSMN NewsFeed - 29 Mar 2024
Maverix Medical Closes Acquisition of Cirrus Bio as Foundation for Diagnostics Platform in Lung Cancer
Maverix Medical Closes Acquisition of Cirrus Bio as Foundation for Diagnostics Platform in Lung Cancer
HSMN NewsFeed - 29 Feb 2024
Spatz Medical Marks Milestone: Spatz3 Adjustable Gastric Balloon Launches in the U.S. in March 2024
Spatz Medical Marks Milestone: Spatz3 Adjustable Gastric Balloon Launches in the U.S. in March 2024
HSMN NewsFeed - 17 Jan 2024
Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted Radiotherapies for Cancer Treatment
Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted Radiotherapies for Cancer Treatment
HSMN NewsFeed - 7 Sep 2023
enGene Appoints Richard Bryce, MBChB, MRCGP, MFPM, as Chief Medical Officer
enGene Appoints Richard Bryce, MBChB, MRCGP, MFPM, as Chief Medical Officer
HSMN NewsFeed - 5 May 2023
Norlase Receives FDA 510(k) Clearance and CE Mark Approval For ECHO(TM) Green Pattern Laser
Norlase Receives FDA 510(k) Clearance and CE Mark Approval For ECHO(TM) Green Pattern Laser
HSMN NewsFeed - 30 Mar 2023
HistoSonics Announces First Ever Kidney Tumor Treatment Using Histotripsy
HistoSonics Announces First Ever Kidney Tumor Treatment Using Histotripsy
HSMN NewsFeed - 22 Mar 2023
Flare Therapeutics Announces Oversubscribed $123 Million Series B Financing
Flare Therapeutics Announces Oversubscribed $123 Million Series B Financing
HSMN NewsFeed - 15 Mar 2023
Medtronic receives CE Mark approval for Affera(TM) Mapping and Ablation System to treat atrial arrhythmias
Medtronic receives CE Mark approval for Affera(TM) Mapping and Ablation System to treat atrial arrhythmias
HSMN NewsFeed - 23 Dec 2022
Hyphens Pharma Licenses Winlevi(R) for All 10 ASEAN countries from Cosmo Pharmaceuticals
Hyphens Pharma Licenses Winlevi(R) for All 10 ASEAN countries from Cosmo Pharmaceuticals
HSMN NewsFeed - 10 Nov 2022
Lipidio Pharmaceuticals Announces Close of Series A Extension Financing, Bringing Total Round to Over $20M
Lipidio Pharmaceuticals Announces Close of Series A Extension Financing, Bringing Total Round to Over $20M
HSMN NewsFeed - 6 Oct 2022
Award-Winning SkinPen(R) Precision Announces New and Expanded Approved Indications
Award-Winning SkinPen(R) Precision Announces New and Expanded Approved Indications
HSMN NewsFeed - 7 Sep 2022
ViewRay Announces China NMPA Approval of its MRIdian(R) MRI-Guided Radiation Therapy for Cancer Patients
ViewRay Announces China NMPA Approval of its MRIdian(R) MRI-Guided Radiation Therapy for Cancer Patients
HSMN NewsFeed - 20 Jul 2022
AbbVie and iSTAR Medical Announce Strategic Alliance for the Treatment of Glaucoma
AbbVie and iSTAR Medical Announce Strategic Alliance for the Treatment of Glaucoma
HSMN NewsFeed - 28 Jun 2022
Advanced NanoTherapies Announces Closing of Oversubscribed $7.2 Million Series A Financing
Advanced NanoTherapies Announces Closing of Oversubscribed $7.2 Million Series A Financing
HSMN NewsFeed - 3 Mar 2022
AiM Medical Robotics Appoints Dr. Jonathan M. Sackier as Chief Medical Officer
AiM Medical Robotics Appoints Dr. Jonathan M. Sackier as Chief Medical Officer
HSMN NewsFeed - 2 Mar 2022
Valencia Technologies Announces FDA Approval of eCoin(R) Therapy to Treat Urinary Urge Incontinence
Valencia Technologies Announces FDA Approval of eCoin(R) Therapy to Treat Urinary Urge Incontinence
HSMN NewsFeed - 26 Jan 2022
Kyverna Therapeutics Closes $85 Million Series B Financing led by Northpond Ventures
Kyverna Therapeutics Closes $85 Million Series B Financing led by Northpond Ventures
HSMN NewsFeed - 26 Nov 2021
Radiaction Medical Unveils Innovative Radiation Protection Solution at RSNA 2021
Radiaction Medical Unveils Innovative Radiation Protection Solution at RSNA 2021
HSMN NewsFeed - 27 Oct 2021
NuVasive to Release Cutting-edge Virtual Reality Training for Lateral, Single-position Spine Surgery
NuVasive to Release Cutting-edge Virtual Reality Training for Lateral, Single-position Spine Surgery
HSMN NewsFeed - 19 Oct 2021
Accuray Unveils VOLO(TM) Ultra, the Latest Innovation for the Radixact(R) System, at ASTRO 2021
Accuray Unveils VOLO(TM) Ultra, the Latest Innovation for the Radixact(R) System, at ASTRO 2021
HSMN NewsFeed - 28 Sep 2021
Open Stent Solution closes €2.5M Seed financing round for its breakthrough open-stent TMVR device
Open Stent Solution closes €2.5M Seed financing round for its breakthrough open-stent TMVR device
HSMN NewsFeed - 9 Sep 2021
Obsidian Therapeutics Announces Closing of $115 Million Series B Financing
Obsidian Therapeutics Announces Closing of $115 Million Series B Financing
HSMN NewsFeed - 22 Jul 2021
Hemab Raises US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders
Hemab Raises US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders
HSMN NewsFeed - 7 Jul 2021
Hyalex Orthopaedics receives FDA Breakthrough Device Designation for novel HYALEX(R) Cartilage System
Hyalex Orthopaedics receives FDA Breakthrough Device Designation for novel HYALEX(R) Cartilage System
HSMN NewsFeed - 7 Jul 2021
Elekta optimizes treatment times for cancer patients via proactive service innovation
Elekta optimizes treatment times for cancer patients via proactive service innovation
HSMN NewsFeed - 17 Jun 2021
Lilly Launches Think Talk Treat Migraine(TM) to Help Improve Diagnosis and Treatment of Migraine
Lilly Launches Think Talk Treat Migraine(TM) to Help Improve Diagnosis and Treatment of Migraine
HSMN NewsFeed - 11 May 2021
Appia Bio Launches With $52 Million Series A Financing and Establishes Scientific Advisory Board
Appia Bio Launches With $52 Million Series A Financing and Establishes Scientific Advisory Board
HSMN NewsFeed - 29 Apr 2021
BD Announces Enrollment in Post-Market Studies of the WavelinQ(TM) Arteriovenous Endovascular Fistula
BD Announces Enrollment in Post-Market Studies of the WavelinQ(TM) Arteriovenous Endovascular Fistula
HSMN NewsFeed - 21 Apr 2021
Medtronic Receives U.S. FDA Approval for Pipeline(TM) Flex Embolization Device with Shield Technology(TM)
Medtronic Receives U.S. FDA Approval for Pipeline(TM) Flex Embolization Device with Shield Technology(TM)
HSMN NewsFeed - 14 Apr 2021
HotSpot Therapeutics Appoints Timothy Reilly as Chief Development Officer
HotSpot Therapeutics Appoints Timothy Reilly as Chief Development Officer
HSMN NewsFeed - 18 Feb 2021
OncoSec Appoints Bridget O'Keeffe, Ph.D. as Vice President of Clinical Development
OncoSec Appoints Bridget O'Keeffe, Ph.D. as Vice President of Clinical Development
HSMN NewsFeed - 16 Feb 2021
Akan Biosciences Announces FDA Acceptance of IND Application for StroMel(TM) in Osteoarthritis of Knee
Akan Biosciences Announces FDA Acceptance of IND Application for StroMel(TM) in Osteoarthritis of Knee
HSMN NewsFeed - 1 Feb 2021
Galderma Receives FDA Approval for Restylane(R) Defyne for Chin Augmentation
Galderma Receives FDA Approval for Restylane(R) Defyne for Chin Augmentation
HSMN NewsFeed - 25 Jan 2021
Candela announces the launch of the Frax Pro(TM) system, the smart way to Frax
Candela announces the launch of the Frax Pro(TM) system, the smart way to Frax
HSMN NewsFeed - 10 Nov 2020
Cytocom, Inc. Appoints Taunia Markvicka, PharmD., MBA, Chief Operating Officer
Cytocom, Inc. Appoints Taunia Markvicka, PharmD., MBA, Chief Operating Officer
HSMN NewsFeed - 27 Oct 2020
Caris Life Sciences Raises $310 Million in Growth Capital from a Broad Syndicate of Leading Investors
Caris Life Sciences Raises $310 Million in Growth Capital from a Broad Syndicate of Leading Investors
HSMN NewsFeed - 10 Sep 2020
Medtronic Study Finds Opioid-Induced Respiratory Depression in the Hospital More Common and Costly
Medtronic Study Finds Opioid-Induced Respiratory Depression in the Hospital More Common and Costly
HSMN NewsFeed - 29 Jul 2020
Truvian Sciences Receives FDA Emergency Use Authorization for Easy Check COVID-19 IgM/IgG(TM) Test
Truvian Sciences Receives FDA Emergency Use Authorization for Easy Check COVID-19 IgM/IgG(TM) Test
HSMN NewsFeed - 24 Jul 2020
Bimekizumab Superior to Cosentyx(R) in Achieving Complete Psoriasis Skin Clearance
Bimekizumab Superior to Cosentyx(R) in Achieving Complete Psoriasis Skin Clearance
HSMN NewsFeed - 22 Jul 2020
BD receives FDA Approval for HPV Test with Extended Genotyping Capabilities
BD receives FDA Approval for HPV Test with Extended Genotyping Capabilities
HSMN NewsFeed - 11 Jun 2020
Sciton Unveils Newest Aesthetic Platform, mJOULE(TM) Featuring BBL HERO(TM) And MOXI(TM)
Sciton Unveils Newest Aesthetic Platform, mJOULE(TM) Featuring BBL HERO(TM) And MOXI(TM)
HSMN NewsFeed - 9 Jun 2020
FDA Grants EUA to Rapid COVID-19 Antibody Testing Product Distributed by Premier Biotech
FDA Grants EUA to Rapid COVID-19 Antibody Testing Product Distributed by Premier Biotech
HSMN NewsFeed - 6 May 2020
Bausch Health And Alfasigma Announce Resolution Of XIFAXAN(R) Intellectual Property Litigation
Bausch Health And Alfasigma Announce Resolution Of XIFAXAN(R) Intellectual Property Litigation
HSMN NewsFeed - 4 May 2020
Enteris BioPharma Appoints Rajiv Khosla, Ph.D., as Chief Executive Officer
Enteris BioPharma Appoints Rajiv Khosla, Ph.D., as Chief Executive Officer
HSMN NewsFeed - 30 Apr 2020
Alpha Cognition, Inc. Receives FDA/PMDA Regulatory Guidance for Alpha-1062 Alzheimer's Therapy
Alpha Cognition, Inc. Receives FDA/PMDA Regulatory Guidance for Alpha-1062 Alzheimer's Therapy
HSMN NewsFeed - 23 Apr 2020
R2 Technologies Receives $10M Second Tranche Investment for Landmark CryoAesthetic Technology
R2 Technologies Receives $10M Second Tranche Investment for Landmark CryoAesthetic Technology
HSMN NewsFeed - 15 Apr 2020
Indivumed Launches Global Oncology Alliance For Personalized Medicine ("Onco AI-Med")
Indivumed Launches Global Oncology Alliance For Personalized Medicine ("Onco AI-Med")
HSMN NewsFeed - 14 Apr 2020
Caris Life Sciences Appoints Dr. Chadi Nabhan as Chairman of Precision Oncology Alliance
Caris Life Sciences Appoints Dr. Chadi Nabhan as Chairman of Precision Oncology Alliance
HSMN NewsFeed - 13 Mar 2020
EMD Serono and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study
EMD Serono and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study
HSMN NewsFeed - 10 Feb 2020
Enteris BioPharma Appoints Gary A. Shangold, MD, as Chief Medical Officer
Enteris BioPharma Appoints Gary A. Shangold, MD, as Chief Medical Officer
HSMN NewsFeed - 10 Feb 2020
Biohaven's Troriluzole Study For Generalized Anxiety Disorder (GAD) Misses Primary Endpoint
Biohaven's Troriluzole Study For Generalized Anxiety Disorder (GAD) Misses Primary Endpoint
HSMN NewsFeed - 28 Jan 2020
John Quisel, JD, PhD Joins Disc Medicine as President and Chief Executive Officer
John Quisel, JD, PhD Joins Disc Medicine as President and Chief Executive Officer
HSMN NewsFeed - 17 Jan 2020
SkinMedica(R) Launches New Instant Bright Eye Cream For Immediate, Visible Results
SkinMedica(R) Launches New Instant Bright Eye Cream For Immediate, Visible Results
HSMN NewsFeed - 2 Jan 2020
Aridis Pharmaceuticals Appoints Michael A. Nazak as Chief Financial Officer
Aridis Pharmaceuticals Appoints Michael A. Nazak as Chief Financial Officer
HSMN NewsFeed - 11 Dec 2019
Bausch & Lomb Introduces enVista(R) Toric MX60ET Intraocular Lens With StableFlex(TM) Technology
Bausch & Lomb Introduces enVista(R) Toric MX60ET Intraocular Lens With StableFlex(TM) Technology
HSMN NewsFeed - 11 Dec 2019
Caris Life Sciences Launches First Ever Molecular AI Product: A Clinical Genomic Profiling Similarity Score
Caris Life Sciences Launches First Ever Molecular AI Product: A Clinical Genomic Profiling Similarity Score
HSMN NewsFeed - 7 Oct 2019
Accelmed Launches Accelmed Ventures II, a New $100 Million Venture HealthTech Fund
Accelmed Launches Accelmed Ventures II, a New $100 Million Venture HealthTech Fund
HSMN NewsFeed - 11 Sep 2019
Immunexpress Appoints Jane Papadaki Markley as VP of Market Development and Commercial Operations
Immunexpress Appoints Jane Papadaki Markley as VP of Market Development and Commercial Operations
HSMN NewsFeed - 3 Sep 2019
Allergan Receives FDA Approval of Juvéderm VOLUMA(R) XC For Mid-Face Injection Via Cannula
Allergan Receives FDA Approval of Juvéderm VOLUMA(R) XC For Mid-Face Injection Via Cannula
HSMN NewsFeed - 12 Aug 2019
binx health Receives FDA 510(k) Clearance For Rapid Point Of Care Platform For Women's Health
binx health Receives FDA 510(k) Clearance For Rapid Point Of Care Platform For Women's Health
HSMN NewsFeed - 1 Aug 2019
Neuronetics(R) Announces First TMS Patient Treated Under New Japan Reimbursement Policy
Neuronetics(R) Announces First TMS Patient Treated Under New Japan Reimbursement Policy
HSMN NewsFeed - 19 Jul 2019
Aridis Pharmaceuticals Receives Orphan Drug Designation From the European Medicines Agency for AR-501
Aridis Pharmaceuticals Receives Orphan Drug Designation From the European Medicines Agency for AR-501
HSMN NewsFeed - 12 Jul 2019
Elekta to Demonstrate Leadership in Precision Radiation Medicine at AAPM with Launch of new QA Portfolio
Elekta to Demonstrate Leadership in Precision Radiation Medicine at AAPM with Launch of new QA Portfolio
HSMN NewsFeed - 12 Jul 2019
Lilly's OVERCOME Observational Study Reveals Inconsistent and Sub-Optimal Treatment Landscape for Migraine
Lilly's OVERCOME Observational Study Reveals Inconsistent and Sub-Optimal Treatment Landscape for Migraine
HSMN NewsFeed - 19 Jun 2019
Bausch & Lomb ULTRA(R) Multifocal for Astigmatism Contact Lenses Now Available in the United States
Bausch & Lomb ULTRA(R) Multifocal for Astigmatism Contact Lenses Now Available in the United States
HSMN NewsFeed - 10 Jun 2019
Aridis Pharmaceuticals Appoints Dr. Susan Windham-Bannister to Board of Directors
Aridis Pharmaceuticals Appoints Dr. Susan Windham-Bannister to Board of Directors
HSMN NewsFeed - 28 Mar 2019
Sciton Unveils New JOULE X Platfor(TM)m During ASLMS, Bringing Realtime Aesthetic Insights Into Your Hands
Sciton Unveils New JOULE X Platfor(TM)m During ASLMS, Bringing Realtime Aesthetic Insights Into Your Hands
HSMN NewsFeed - 5 Feb 2019
Lutronic And Syneron-Candela(R) Announce Settlement Of Patent Infringement Lawsuit
Lutronic And Syneron-Candela(R) Announce Settlement Of Patent Infringement Lawsuit
HSMN NewsFeed - 31 Jan 2019
IGM Biosciences Appoints M. Kathleen Behrens, Ph.D., to Board of Directors
IGM Biosciences Appoints M. Kathleen Behrens, Ph.D., to Board of Directors
HSMN NewsFeed - 28 Jan 2019
First-In-Human Case Using Biostage's Bioengineered Esophageal Implant is Presented at Major Surgical Meeting
First-In-Human Case Using Biostage's Bioengineered Esophageal Implant is Presented at Major Surgical Meeting
HSMN NewsFeed - 24 Jan 2019
Merck KGaA, Darmstadt, Germany, Grants Exclusive License to Vertex for Two DNA Damage Response Inhibitors
Merck KGaA, Darmstadt, Germany, Grants Exclusive License to Vertex for Two DNA Damage Response Inhibitors
HSMN NewsFeed - 21 Dec 2018
Mallinckrodt And NPXe Announce First Patient Enrolled In Phase 3 Trial Of Inhaled Xenon Gas Therapy
Mallinckrodt And NPXe Announce First Patient Enrolled In Phase 3 Trial Of Inhaled Xenon Gas Therapy
HSMN NewsFeed - 20 Dec 2018
Merck KGaA, Darmstadt, Germany, Assigns Chimeric Antigen Receptor T-cell (CAR-T) Rights to Intrexon
Merck KGaA, Darmstadt, Germany, Assigns Chimeric Antigen Receptor T-cell (CAR-T) Rights to Intrexon
HSMN NewsFeed - 26 Nov 2018
BlueRock Therapeutics Appoints Min Wang, J.D., Ph.D., as Chief Legal and Administrative Officer
BlueRock Therapeutics Appoints Min Wang, J.D., Ph.D., as Chief Legal and Administrative Officer
HSMN NewsFeed - 21 Nov 2018
FDA Closes Inquiry Regarding IHCTOA Letter Regarding Sciton's diVa(R) Laser
FDA Closes Inquiry Regarding IHCTOA Letter Regarding Sciton's diVa(R) Laser
HSMN NewsFeed - 8 Nov 2018
Mr. Matthew Dallas and Mr. Jeffrey Young Appointed to Biostage Board of Directors
Mr. Matthew Dallas and Mr. Jeffrey Young Appointed to Biostage Board of Directors
HSMN NewsFeed - 5 Nov 2018
Galderma Announces FDA Approval of Restylane(R) Lyft For Midface Injection via Cannula
Galderma Announces FDA Approval of Restylane(R) Lyft For Midface Injection via Cannula
HSMN NewsFeed - 26 Oct 2018
Mayne Pharma Acquires FDA-approved halobetasol foam, Complementing US Dermatology Portfolio
Mayne Pharma Acquires FDA-approved halobetasol foam, Complementing US Dermatology Portfolio
HSMN NewsFeed - 18 Oct 2018
Olympus 3D/FlexDex(R) for Minimal Access Surgery Simplifies Suturing, Redefines Robotics
Olympus 3D/FlexDex(R) for Minimal Access Surgery Simplifies Suturing, Redefines Robotics
HSMN NewsFeed - 5 Oct 2018
ZEISS Receives FDA Approval for ReLEx SMILE, Expanding Myopia Treatment to Patients with Astigmatism
ZEISS Receives FDA Approval for ReLEx SMILE, Expanding Myopia Treatment to Patients with Astigmatism
HSMN NewsFeed - 20 Sep 2018
BlueRock Therapeutics Appoints Shane Kovacs as Chief Business and Financial Officer
BlueRock Therapeutics Appoints Shane Kovacs as Chief Business and Financial Officer
HSMN NewsFeed - 31 Aug 2018
Rehan Verjee to Lead EMD Serono as Company Advances its Innovative Medicines Strategy in North America
Rehan Verjee to Lead EMD Serono as Company Advances its Innovative Medicines Strategy in North America
HSMN NewsFeed - 9 Jul 2018
Mylan Adds to Central Nervous System Portfolio With Launch of Generic Exelon(R) Patch
Mylan Adds to Central Nervous System Portfolio With Launch of Generic Exelon(R) Patch
HSMN NewsFeed - 15 Jun 2018
ACell, Inc. Announces Ventral Hernia Data Presented at Abdominal Wall Reconstruction Conference
ACell, Inc. Announces Ventral Hernia Data Presented at Abdominal Wall Reconstruction Conference
HSMN NewsFeed - 12 Jun 2018
Vergent Bioscience Raises $8.7 Million in Series A Financing Led by Spring Mountain Capital
Vergent Bioscience Raises $8.7 Million in Series A Financing Led by Spring Mountain Capital
HSMN NewsFeed - 30 May 2018
Olympus Launches the DualKnife J, an ESD Electrosurgical Knife That Shortens Procedure Time
Olympus Launches the DualKnife J, an ESD Electrosurgical Knife That Shortens Procedure Time
HSMN NewsFeed - 29 May 2018
Zeto Announces First Dry Electrode, Wireless EEG Headset Approved by FDA for Clinical Use
Zeto Announces First Dry Electrode, Wireless EEG Headset Approved by FDA for Clinical Use
HSMN NewsFeed - 28 May 2018
Luye Pharma Acquires AstraZeneca's Signature Products Seroquel and Seroquel XR
Luye Pharma Acquires AstraZeneca's Signature Products Seroquel and Seroquel XR
HSMN NewsFeed - 18 May 2018
FDA Approves Aimovig(TM) (erenumab-aooe), A Novel Treatment Developed Specifically For Migraine Prevention
FDA Approves Aimovig(TM) (erenumab-aooe), A Novel Treatment Developed Specifically For Migraine Prevention
HSMN NewsFeed - 14 May 2018
Grifols Expands its Blood Typing Solutions Portfolio in the United States with Antisera Reagents
Grifols Expands its Blood Typing Solutions Portfolio in the United States with Antisera Reagents
HSMN NewsFeed - 3 May 2018
CytRx Corporation Names Eric L. Curtis as Its President and Chief Operating Officer
CytRx Corporation Names Eric L. Curtis as Its President and Chief Operating Officer
HSMN NewsFeed - 3 May 2018
Paradigm Spine Announces NASS Coverage Policy Recommendation For coflex(R) Interlaminar Stabilization(R)
Paradigm Spine Announces NASS Coverage Policy Recommendation For coflex(R) Interlaminar Stabilization(R)
HSMN NewsFeed - 2 May 2018
Bausch & Lomb ULTRA(R) Contact Lenses Receive FDA Approval for Extended Wear Indication
Bausch & Lomb ULTRA(R) Contact Lenses Receive FDA Approval for Extended Wear Indication
HSMN NewsFeed - 2 May 2018
Paradigm Spine Receives FDA Pre-Market Approval (PMA) For First Of Its Kind Disposable Instrument Kit
Paradigm Spine Receives FDA Pre-Market Approval (PMA) For First Of Its Kind Disposable Instrument Kit
HSMN NewsFeed - 25 Apr 2018
Dermtreat Appoints Nishan de Silva, M.D., as CEO; Establishes North American Headquarters in San Diego
Dermtreat Appoints Nishan de Silva, M.D., as CEO; Establishes North American Headquarters in San Diego
HSMN NewsFeed - 16 Apr 2018
Apitope Announces Positive Results with Novel Treatment for Graves' Disease
Apitope Announces Positive Results with Novel Treatment for Graves' Disease
HSMN NewsFeed - 4 Apr 2018
Arvinas Completes $55 Million Series C Financing to Advance Protein Degradation Platform
Arvinas Completes $55 Million Series C Financing to Advance Protein Degradation Platform
HSMN NewsFeed - 13 Mar 2018
Cogmedix Welcomes David Fraser as New Senior Vice President of Operations
Cogmedix Welcomes David Fraser as New Senior Vice President of Operations
HSMN NewsFeed - 6 Mar 2018
Wendy Sussman Joins EMD Serono as Vice President of U.S. Healthcare Government & Public Affairs
Wendy Sussman Joins EMD Serono as Vice President of U.S. Healthcare Government & Public Affairs
HSMN NewsFeed - 27 Feb 2018
VitalConnect Launches Continuous Patient Monitoring Platform in Hospitals Nationwide
VitalConnect Launches Continuous Patient Monitoring Platform in Hospitals Nationwide
HSMN NewsFeed - 22 Feb 2018
Kallyope Inc. Announces $66M Series B Financing to Advance Programs Targeting the Gut-Brain Axis
Kallyope Inc. Announces $66M Series B Financing to Advance Programs Targeting the Gut-Brain Axis
HSMN NewsFeed - 8 Feb 2018
Novo Nordisk Launches Rebinyn(R) in the United States for People with Hemophilia B
Novo Nordisk Launches Rebinyn(R) in the United States for People with Hemophilia B
HSMN NewsFeed - 16 Jan 2018
RXi Pharmaceuticals Announces Business Strategy to Focus on Immuno-Oncology Programs to Accelerate Growth
RXi Pharmaceuticals Announces Business Strategy to Focus on Immuno-Oncology Programs to Accelerate Growth
HSMN NewsFeed - 4 Jan 2018
Neurogastrx, Inc. Raises $45M Series A To Bring Lead GI Candidate Through Proof Of Concept
Neurogastrx, Inc. Raises $45M Series A To Bring Lead GI Candidate Through Proof Of Concept
HSMN NewsFeed - 18 Dec 2017
Novartis multiple sclerosis therapy fingolimod granted FDA Breakthrough Therapy designation for pediatric MS
Novartis multiple sclerosis therapy fingolimod granted FDA Breakthrough Therapy designation for pediatric MS
HSMN NewsFeed - 14 Dec 2017
Protagonist Therapeutics Appoints Sarah Noonberg, M.D., Ph.D. to the Board of Directors
Protagonist Therapeutics Appoints Sarah Noonberg, M.D., Ph.D. to the Board of Directors
HSMN NewsFeed - 7 Dec 2017
VitalConnect Secures Fifth U.S. FDA Clearance for Patient Monitoring Device
VitalConnect Secures Fifth U.S. FDA Clearance for Patient Monitoring Device
HSMN NewsFeed - 7 Dec 2017
John Walsh, M.D. Joins EMD Serono as Vice President of Neurology & Immunology, US Medical Affairs
John Walsh, M.D. Joins EMD Serono as Vice President of Neurology & Immunology, US Medical Affairs
HSMN NewsFeed - 5 Dec 2017
Cocoon Biotech Appoints Dr. Annalisa Jenkins as Executive Chair of the Board
Cocoon Biotech Appoints Dr. Annalisa Jenkins as Executive Chair of the Board
HSMN NewsFeed - 4 Dec 2017
Merck's Mavenclad (Cladribine Tablets) Approved for Relapsing-Remitting Multiple Sclerosis in Canada
Merck's Mavenclad (Cladribine Tablets) Approved for Relapsing-Remitting Multiple Sclerosis in Canada
HSMN NewsFeed - 1 Dec 2017
EMD Serono Appoints Zhen Su, M.D., MBA to Chief Medical Officer, North America
EMD Serono Appoints Zhen Su, M.D., MBA to Chief Medical Officer, North America
HSMN NewsFeed - 30 Nov 2017
Fractyl Completes $44 Million Series D Financing to Advance New Treatment for Type 2 Diabetes
Fractyl Completes $44 Million Series D Financing to Advance New Treatment for Type 2 Diabetes
HSMN NewsFeed - 9 Nov 2017
NICE Recommends Mavenclad (Cladribine Tablets) for Highly Active Multiple Sclerosis
NICE Recommends Mavenclad (Cladribine Tablets) for Highly Active Multiple Sclerosis
HSMN NewsFeed - 23 Oct 2017
EMD Serono Appoints Robert Truckenmiller to Senior Vice President of Market Access & Customer Solutions
EMD Serono Appoints Robert Truckenmiller to Senior Vice President of Market Access & Customer Solutions
HSMN NewsFeed - 21 Sep 2017
European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma
European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma
HSMN NewsFeed - 20 Sep 2017
Arvinas Appoints Dr. John Houston as President and Chief Executive Officer
Arvinas Appoints Dr. John Houston as President and Chief Executive Officer
HSMN NewsFeed - 31 Aug 2017
RegeneRx Completes License Expansion for RGN-137 in Europe, S. Korea, Japan, Canada and Australia
RegeneRx Completes License Expansion for RGN-137 in Europe, S. Korea, Japan, Canada and Australia
HSMN NewsFeed - 28 Aug 2017
CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform
CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform
HSMN NewsFeed - 7 Aug 2017
Biostage Announces the Use of Its Esophageal Implant Product Candidate in a Patient
Biostage Announces the Use of Its Esophageal Implant Product Candidate in a Patient
HSMN NewsFeed - 21 Jul 2017
EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
HSMN NewsFeed - 11 May 2017
STAAR Surgical Announces CE Mark Approval for the EVO+ Visian ICL with Aspheric (EDOF) Optic
STAAR Surgical Announces CE Mark Approval for the EVO+ Visian ICL with Aspheric (EDOF) Optic
HSMN NewsFeed - 10 May 2017
Bioness and Ottobock Announce Strategic European Distribution Partnership
Bioness and Ottobock Announce Strategic European Distribution Partnership
HSMN NewsFeed - 9 May 2017
FDA Grants BAVENCIO(R) (avelumab) Approval for a Common Type of Advanced Bladder Cancer
FDA Grants BAVENCIO(R) (avelumab) Approval for a Common Type of Advanced Bladder Cancer
HSMN NewsFeed - 30 Mar 2017
Third Rock Ventures Launches Tango Therapeutics with $55 Million Series A Investment
Third Rock Ventures Launches Tango Therapeutics with $55 Million Series A Investment
HSMN NewsFeed - 27 Mar 2017
Bridge Medicines Appoints William J. Polvino, M.D., As Chief Executive Officer
Bridge Medicines Appoints William J. Polvino, M.D., As Chief Executive Officer
HSMN NewsFeed - 24 Mar 2017
Richard Peterson Joins Sienna Biopharmaceuticals As Chief Financial Officer
Richard Peterson Joins Sienna Biopharmaceuticals As Chief Financial Officer
HSMN NewsFeed - 15 Mar 2017
Bausch & Lomb Introduces Biotrue(R) ONEday For Astigmatism Contact Lenses
Bausch & Lomb Introduces Biotrue(R) ONEday For Astigmatism Contact Lenses
HSMN NewsFeed - 16 Feb 2017
Valeant Receives FDA Approval Of SILIQ(TM) (Brodalumab) For Moderate-To-Severe Plaque Psoriasis
Valeant Receives FDA Approval Of SILIQ(TM) (Brodalumab) For Moderate-To-Severe Plaque Psoriasis
HSMN NewsFeed - 2 Feb 2017
Glaukos Corporation Promotes Chris M. Calcaterra to Chief Operating Officer
Glaukos Corporation Promotes Chris M. Calcaterra to Chief Operating Officer
HSMN NewsFeed - 1 Feb 2017
Syneron Medical Strengthens Senior Management Team with Appointment of Chief Human Resources Officer
Syneron Medical Strengthens Senior Management Team with Appointment of Chief Human Resources Officer
HSMN NewsFeed - 13 Jan 2017
Merck KGaA, Darmstadt, Germany, and Palantir Launch New Healthcare Acceleration Partnership
Merck KGaA, Darmstadt, Germany, and Palantir Launch New Healthcare Acceleration Partnership
HSMN NewsFeed - 11 Jan 2017
US Endovascular Announces John F. Vacha & Paul A. Tyska Join The Partnership
US Endovascular Announces John F. Vacha & Paul A. Tyska Join The Partnership
HSMN NewsFeed - 15 Dec 2016
ContraVir Appoints Business Development Executive Tamar Howson to its Board of Directors
ContraVir Appoints Business Development Executive Tamar Howson to its Board of Directors
HSMN NewsFeed - 29 Nov 2016
Cynosure Receives CFDA Clearance to Market the Icon(TM) Aesthetic System in China
Cynosure Receives CFDA Clearance to Market the Icon(TM) Aesthetic System in China
HSMN NewsFeed - 22 Nov 2016
Allergan Receives FDA Clearance for the XEN(R) Gel Stent, a New Surgical Treatment for Refractory Glaucoma
Allergan Receives FDA Clearance for the XEN(R) Gel Stent, a New Surgical Treatment for Refractory Glaucoma
HSMN NewsFeed - 15 Nov 2016
Integrated Endoscopy Significantly Expands Management Team in Advance of U.S. Product Launch
Integrated Endoscopy Significantly Expands Management Team in Advance of U.S. Product Launch
HSMN NewsFeed - 20 Oct 2016
Avita Medical's ReCell(R) devices now treating burns in South Africa and Benelux
Avita Medical's ReCell(R) devices now treating burns in South Africa and Benelux
HSMN NewsFeed - 11 Oct 2016
Rapid Micro Biosystems Announces New Vice President of Product Development
Rapid Micro Biosystems Announces New Vice President of Product Development
HSMN NewsFeed - 8 Jul 2016
William D. Waddill, Calithera CFO, Elected to Protagonist Therapeutics Board
William D. Waddill, Calithera CFO, Elected to Protagonist Therapeutics Board
HSMN NewsFeed - 7 Jul 2016
QT Vascular Receives CE Mark Clearance for Chocolate Heart(TM), a Novel Drug-Coated Coronary Balloon
QT Vascular Receives CE Mark Clearance for Chocolate Heart(TM), a Novel Drug-Coated Coronary Balloon
HSMN NewsFeed - 6 Jul 2016
US FDA pathway opens to SCENESSE(R) following Fast Track designation for treatment of EPP
US FDA pathway opens to SCENESSE(R) following Fast Track designation for treatment of EPP
HSMN NewsFeed - 29 Jun 2016
Biostage Files for FDA Orphan Drug Designation for Cellspan(TM) Esophageal Implant
Biostage Files for FDA Orphan Drug Designation for Cellspan(TM) Esophageal Implant
HSMN NewsFeed - 6 Jun 2016
Vitae Pharmaceuticals Announces Appointment of Carole Sable, M.D., as Chief Medical Officer
Vitae Pharmaceuticals Announces Appointment of Carole Sable, M.D., as Chief Medical Officer
HSMN NewsFeed - 1 Jun 2016
Elekta’s Leksell Gamma Knife Icon Cleared for Use in Japan and United States
Elekta’s Leksell Gamma Knife Icon Cleared for Use in Japan and United States
HSMN NewsFeed - 4 May 2016
Notal Vision Announces Appointment of Quinton Oswald as Chief Executive Officer
Notal Vision Announces Appointment of Quinton Oswald as Chief Executive Officer
HSMN NewsFeed - 6 Apr 2016
Merck and Sysmex Inostics Receive CE Mark Approval for Liquid Biopsy test for Colorectal Cancer Patients
Merck and Sysmex Inostics Receive CE Mark Approval for Liquid Biopsy test for Colorectal Cancer Patients
HSMN NewsFeed - 7 Mar 2016
Avant Diagnostics and Amarantus Diagnostics to Combine Operations With Theranostics Health
Avant Diagnostics and Amarantus Diagnostics to Combine Operations With Theranostics Health
HSMN NewsFeed - 7 Mar 2016
Avita Medical Announces U.S. FDA Approval for Increase in Compassionate Use of ReCell(R) Patient Cases
Avita Medical Announces U.S. FDA Approval for Increase in Compassionate Use of ReCell(R) Patient Cases
HSMN NewsFeed - 1 Mar 2016
Mazor Robotics' Renaissance(R) Guidance System Achieves New Clinical Milestone
Mazor Robotics' Renaissance(R) Guidance System Achieves New Clinical Milestone
HSMN NewsFeed - 24 Feb 2016
Pixium Vision Implants IRIS(R) II, First Epi-Retinal Implant with 150 Electrodes
Pixium Vision Implants IRIS(R) II, First Epi-Retinal Implant with 150 Electrodes
HSMN NewsFeed - 9 Feb 2016
Aytu BioScience Announces First Commercial Sales for Company's MiOXSYS(TM) System for Male Infertility
Aytu BioScience Announces First Commercial Sales for Company's MiOXSYS(TM) System for Male Infertility
Additional items found! 500
Members Archive contains
500 additional stories matching:
IgM
(Password required)
IgM
(Password required)
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!